Latest Breaking News On - Soumit roy - Page 1 : comparemela.com

StockWatch: Like a Bolt from the Blue, Cancer Drug Developer Nosedives

StockWatch: Like a Bolt from the Blue, Cancer Drug Developer Nosedives
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Michaeln alonsoEdgarg englemanSarah nemecRoche perjetaMichael alonsoWillie quinnMichael schmidtRandall schatzmanDainam grayboschStephen willey stifelSoumit royBristol myers squibbEdith perezStanford university school of medicineEdward white hc wainwright coImmunotherapy program of the stanford cancer institute

Aptose Biosciences Inc (NASDAQ:APTO) Q4 2023 Earnings Call Transcript

Operator: Good afternoon. My name is Jonathan and I will be your conference operator today.

Soumit royAptose biosciencesSusan pietropaoloWilliam riceRafael bejarFletcher payneMd anderson cancer centerAptose biosciences incJones researchCall transcript marchAptose biosciences conference callFourth quarterYear ended decemberSenior vice presidentChief medical officerChief financial

Oncolytics Biotech Inc (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Oncolytics Biotech s Fourth Quarter and Full Year 2023 Conference Call. All participants are now in a listen-only mode.

San diegoUnited statesLouise chenJohn newmanMatt coffeyPatrick trucchioSoumit royJon pattonAllison hagermanCarvey leungPat andrewsLuis santosTom heinemanManufacturing organizationContract developmentProduct development

Anavex Life Sciences Corp (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript February 7, 2024 Anavex Life Sciences Corp. beats earnings expectations. Reported EPS is $-0.0001, expectations were $-0.14. AVXL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. Welcome to […]

United statesSandra boenischChristopher misslingSoumit royJones researchTrademark officeFood effectReceptor agonistFrontotemporal dementiaUnited states patentPrincipal financial officerQuality egg brandsQuality creatine supplementsAnavex life sciences corpAnavex life sciencesAnavex life sciences fiscal

How Soon Might Anavex s Alzheimer s Drug Be Approved? The Good/Bad News (NASDAQ:AVXL)

How Soon Might Anavex s Alzheimer s Drug Be Approved? The Good/Bad News (NASDAQ:AVXL)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesChristopher misslingSoumit royAnavex life sciencesEuropean agencyAlzheimer phaseAccelerated approvalAccelerated approval pathwayDisease dementia phaseDisease dementia